Data for: Effect of Dexmedetomidine Combined Anesthesia on Motor-Evoked Potentials during Brain Tumor Surgery

Published: 31 March 2020| Version 1 | DOI: 10.17632/tjb7myc7wd.1
Contributors:
Han Gil Seo,
Woo Hyung Lee,
Chul-Kee Park,
Hee-Pyoung Park,
Sung-Min Kim

Description

These data include de-identified clinical information and intraoperative neuromonitoring recordings of patients with brain tumor collected from one tertiary hospital. #Labeling Dex 0: Precedex - 1: Precedex + Pre_hypesthesia 0: hypesthesia(-) 1: hypesthesia(+) resect_extent 1: GTR: complete resection 2: NTR: <3-mm thin residual FLAIR around the rim of the resection cavity only 3: STR: residual nodular fluid-attenuated inversion recovery signal abnormality 4: Bx Rt/Lt/Midline 1: Right 2: Left 3: Both abrupt no event: 0 gradual: 1 abrupt: 2 Bilateral 0: no event 1: unilateral 2: bilateral Pathology_type 1: meningioma 2: glioblastoma 3: glioma 4: schuwanoma 5: vascular malformation or hemangioma 6. brain meta 7. etc Lesion location 1: SupraT, Cortical 2: SupraT, Subcortical 3: SupraT (Cort + SubC) 4: InfraT 5: Extensive Pre_HCP 0: HSP(-) 1: HSP(+) MEP_Event 1: No event 2: Temporary deterioration <50% 3: Temporary loss 4: Persistent deterioration <50% 5: Persistent loss M_Outcome 1: No motor deterioration 2: Transient deterioration (<1wk or discharge) 3: Persistent deterioration M_Prediction 1: TP 2: TN 3: FP 4: FN SEP_Event 1: No event 2: Temporary deterioration <50% 3: Temporary loss 4: Persistent deterioration <50% 5: Persistent loss SEP_Event_type 0: No event 1: Bilateral 2: Unilateral S_Outcome 1: No sensory deterioration 2: Transient deterioration (<1wk or discharge) 3: Persistent deterioration S_Prediction 1: TP 2: TN 3: FP 4: FN

Files